These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25511972)

  • 1. ToxRead: a tool to assist in read across and its use to assess mutagenicity of chemicals.
    Gini G; Franchi AM; Manganaro A; Golbamaki A; Benfenati E
    SAR QSAR Environ Res; 2014; 25(12):999-1011. PubMed ID: 25511972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Read-Across Tools.
    Manganelli S; Benfenati E
    Methods Mol Biol; 2016; 1425():305-22. PubMed ID: 27311471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating QSAR and read-across for environmental assessment.
    Benfenati E; Roncaglioni A; Petoumenou MI; Cappelli CI; Gini G
    SAR QSAR Environ Res; 2015; 26(7-9):605-18. PubMed ID: 26535447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards quantitative read across: Prediction of Ames mutagenicity in a large database.
    Benigni R
    Regul Toxicol Pharmacol; 2019 Nov; 108():104434. PubMed ID: 31374229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of structure-activity relationship and artificial intelligence systems to improve in silico prediction of ames test mutagenicity.
    Mazzatorta P; Tran LA; Schilter B; Grigorov M
    J Chem Inf Model; 2007; 47(1):34-8. PubMed ID: 17238246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical Rules for Read-Across and In Silico Models of Mutagenicity.
    Benfenati E; Manganelli S; Giordano S; Raitano G; Manganaro A
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2015; 33(4):385-403. PubMed ID: 26403277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practice of expert review by read-across using QSAR Toolbox.
    Fukuchi J; Kitazawa A; Hirabayashi K; Honma M
    Mutagenesis; 2019 Mar; 34(1):49-54. PubMed ID: 30690463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Similarity in Computational Toxicology.
    Floris M; Olla S
    Methods Mol Biol; 2018; 1800():171-179. PubMed ID: 29934892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
    Benigni R
    J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment Prioritization on a Large Mutagenicity Dataset.
    Floris M; Raitano G; Medda R; Benfenati E
    Mol Inform; 2017 Jul; 36(7):. PubMed ID: 28032691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
    Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a hybrid read-across method to evaluate chemical toxicity based on chemical structure and biological data.
    Guo Y; Zhao L; Zhang X; Zhu H
    Ecotoxicol Environ Saf; 2019 Aug; 178():178-187. PubMed ID: 31004930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
    Landry C; Kim MT; Kruhlak NL; Cross KP; Saiakhov R; Chakravarti S; Stavitskaya L
    Regul Toxicol Pharmacol; 2019 Dec; 109():104488. PubMed ID: 31586682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in silico models for prediction of mutagenicity.
    Bakhtyari NG; Raitano G; Benfenati E; Martin T; Young D
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(1):45-66. PubMed ID: 23534394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity.
    Buist H; Aldenberg T; Batke M; Escher S; Klein Entink R; Kühne R; Marquart H; Pauné E; Rorije E; Schüürmann G; Kroese D
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):170-81. PubMed ID: 23357514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
    Ahlberg E; Amberg A; Beilke LD; Bower D; Cross KP; Custer L; Ford KA; Van Gompel J; Harvey J; Honma M; Jolly R; Joossens E; Kemper RA; Kenyon M; Kruhlak N; Kuhnke L; Leavitt P; Naven R; Neilan C; Quigley DP; Shuey D; Spirkl HP; Stavitskaya L; Teasdale A; White A; Wichard J; Zwickl C; Myatt GJ
    Regul Toxicol Pharmacol; 2016 Jun; 77():1-12. PubMed ID: 26879463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Commission for Protection Against Environmental Mutagens and Carcinogens. Application of SAR methods to non-congeneric data bases associated with carcinogenicity and mutagenicity: issues and approaches.
    Richard AM
    Mutat Res; 1994 Feb; 305(1):73-97. PubMed ID: 7508549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR and metabolic assessment tools in the assessment of genotoxicity.
    Worth AP; Lapenna S; Serafimova R
    Methods Mol Biol; 2013; 930():125-62. PubMed ID: 23086840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.